{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:40:03Z","timestamp":1750534803840,"version":"3.41.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Clinical overlap with multiple other neurological diseases makes the diagnosis of autoimmune encephalitis challenging; consequently, a broad range of neurological diseases are misdiagnosed as autoimmune encephalitis. A 58-year-old man presented with abnormal behavior, irritability for 3 years, oculomotor disturbance, unsteady walking, and dysphagia and was suspected as having anti\u2013dipeptidyl-peptidase\u2013like protein 6 (DPPX) encephalitis as the anti-DPPX antibody was positive in the serum. However, the therapeutic effect of immunotherapy was unsatisfactory. Subsequently, colocalization of increased midbrain signals was observed in neuroinflammation PET using [<jats:sup>18<\/jats:sup>F]DPA-714 and in tau PET using [<jats:sup>18<\/jats:sup>F]florzolotau, suggesting the diagnosis of progressive supranuclear palsy.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005062","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T18:08:56Z","timestamp":1706206136000},"page":"346-347","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Colocalization of Increased Midbrain Signals in Neuroinflammation and Tau PET Imaging Suggests the Diagnosis of Progressive Supranuclear Palsy"],"prefix":"10.1097","volume":"49","author":[{"given":"Jiaying","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjie","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guixian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,1,24]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","year":"2016","journal-title":"Lancet Neurol"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1212\/WNL.0000000000000991","article-title":"DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients","volume":"83","year":"2014","journal-title":"Neurology"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.nucmedbio.2011.10.012","article-title":"Initial evaluation in healthy humans of [18F]DPA-714, a potential PET biomarker for neuroinflammation","volume":"39","year":"2012","journal-title":"Nucl Med Biol"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"577879","DOI":"10.1016\/j.jneuroim.2022.577879","article-title":"Activated microglia by 18F-DPA714 PET in a case of anti-LGI1 autoimmune encephalitis","volume":"368","year":"2022","journal-title":"J Neuroimmunol"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1007\/s00259-023-06190-8","article-title":"Characterization of neuroinflammation pattern in anti-LGI1 encephalitis based on TSPO PET and symptom clustering analysis","volume":"50","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S1474-4422(17)30157-6","article-title":"Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches","volume":"16","year":"2017","journal-title":"Lancet Neurol"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuron.2020.09.042","article-title":"High-contrast in vivo imaging of tau pathologies in Alzheimer's and non-Alzheimer's disease tauopathies","volume":"109","year":"2021","journal-title":"Neuron"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00401-020-02158-2","article-title":"Distribution patterns of tau pathology in progressive supranuclear palsy","volume":"140","year":"2020","journal-title":"Acta Neuropathol"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00259-022-06104-0","article-title":"18F-florzolotau PET imaging captures the distribution patterns and regional vulnerability of tau pathology in progressive supranuclear palsy","volume":"50","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"107426","DOI":"10.1016\/j.isci.2023.107426","article-title":"Improved interpretation of 18F-florzolotau PET in progressive supranuclear palsy using a normalization-free deep-learning classifier","volume":"26","year":"2023","journal-title":"iScience"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/jamaneurol.2022.4251","article-title":"Autoimmune encephalitis misdiagnosis in adults","volume":"80","year":"2023","journal-title":"JAMA Neurol"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/ana.25911","article-title":"Neuroinflammation and tau colocalize in vivo in progressive supranuclear palsy","volume":"88","year":"2020","journal-title":"Ann Neurol"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jnnp-2020-325549","article-title":"Neuroinflammation predicts disease progression in progressive supranuclear palsy","volume":"92","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"bib14-20250621","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1093\/brain\/awaa276","article-title":"18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases","volume":"143","year":"2020","journal-title":"Brain"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005062","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:05:46Z","timestamp":1750532746000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,24]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005062","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2024,1,24]]}}}